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INTRODUCTION
With the increase in the use of endoscopes for diagnostic 
and therapeutic purposes, the importance of reprocessing has 
become a top priority to minimize spread of infection through 
endoscopes. Since the late 1970s there have been sporadic re-
ports of nosocomial infections linked to endoscopic proce-
dures. Bacterial infections have been acquired during endos-
Clin Endosc  2011;44:109-115
  Copyright © 2011 The Korean Society of Gastrointestinal Endoscopy  109
copy, caused for example by Salmonella spp., Helicobacter 
pylori, and Pseudomonas spp.
1-4 Transmission of viruses such 
as hepatitis B and C during endoscopy was not an exception
5,6 
and transmission of fungi via endoscopic procedures has also 
been documented.
7-9
Since endoscopes are reusable apparatus, cleaning and dis-
infection are very important to minimize the spread of infec-
tion through endoscopes. Endoscopes are classified as semicri-
tical item and thus, high-level disinfection (i.e., the removal of 
all bacteria except for resistant bacterial spores) is required.
10 
To standardize and improve disinfection efficacy, automated 
endoscope reprocessors (AERs) have been developed and are 
being widely used. The AERs perform automatic flushing, fill-
ing, and rinsing processes, with a preset timing for soaking ac-
cording to the disinfectant or liquid chemical germicides being 
used. They guarantee proper disinfection of the internal chan-
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Comparison of Endoscope Disinfectants
nels and minimize exposure to disinfectants or fumes, thus 
causing less risk of skin sensitivity and allergic reactions to 
the medical staffs.
Disinfectants that have been widely used until now include 
glutaraldehyde, orthophthaldehyde (OPA), peracetic acid, su-
peroxidized water, and chlorine dioxide. Among these agents, 
OPA is one of the most widely used and recently developed 
disinfectant
11 that has been shown to have better microbiolo-
gical efficacy compared to that of glutaraldehyde.
10 However, 
there have been reports that exposure to OPA vapors from the 
endoscopes disinfected with OPA could cause irritation to the 
respiratory tract and eyes and also anaphylactic reaction.
11 Th-
erefore, to enhance safety and improve efficacy of endoscope 
reprocessing, many efforts are being put into making newer 
disinfectants and/or combining existing disinfectants. Poly-
hexamethylenebiguanide (PHMB) is a quaternary ammonium 
compound and polymeric cationic anti-microbial agent that 
has been used in ophthalmic solutions, peri-operative clean-
ing solutions, etc.
12 The safety profile of PHMB is also excellent 
and has broad antimicrobial spectrum including Gram-posi-
tive and Gram-negative bacteria, intracellular bacteria, fungi, 
and viruses such as HIV and HSV. Alkyldimethylbenzylam-
monium chloride (DBAC) is also a quaternary ammonium 
compound with antimicrobial activity.
In addition to the evolution of disinfectants, more advanced 
and upgraded AERs are also being developed to augment cost-
effectiveness of endoscope reprocessing, in part by incorpo-
rating ultrasonographic cleaning to enhance the efficacy and 
shorten the time required for reprocessing procedure. OER-
A (Olympus Optical, Tokyo, Japan) is one of the widely used 
endoscope reprocessor that has integrated ultrasonographic 
cleaning into the AERs and uses OPA or peracetic acid as dis-
infectant. Recently, a novel endoscope processor, COOLEN-
DO (APEX Korea, Seoul, Korea) has been released to market 
in Korea (Table 1). This device uses the combined solution of 
PHMB-DBAC as disinfectant and also applies ultrasonogra-
phic cleaning. Compared with OER-A, endoscope reprocess-
ing using COOLEND takes shorter time and is cost effective. 
Until now, PHMB has not been applied for endoscope repro-
cessing and COOLENDO is the first AER that has utilized this 
agent as a disinfectant. The aim of this study is to compare 
the efficacy of PHMB-DBAC and OPA used as disinfectants 
in ultrasonographic cleaning incorporated AERs, COOLEN-
DO, and OER-A, respectively.
MATERIALS AND METHODS
Patients and methods 
This study was carried out from August 2010 to January 2011 
at Korea University Anam Hospital Endoscopy Unit. A total of 
16 flexible upper endoscopes (GIF-H260, GIF-Q260; Olym-
pus Optical) that had been used for diagnostic purposes, re-
gardless of the underlying diseases of the patients, were select-
ed to be randomly assigned for endoscope reprocessings. The 
endoscopes that had been used to perform therapeutic pro-
cedures were excluded from the current study. The mean ser-
vice age of the endoscopes was 57 months. Endoscopic repro-
cessing was carried out by medical staffs with more than 3 
years’ experience in this procedure and in accordance with the 
guideline recommended by Korean Society of Gastrointestinal 
Endoscopy.
13 In short, as soon as endoscopic examination was 
finished, the outer surface of the endoscope insertion tube was 
wiped with enzyme detergent moistened gauze, and the work-
ing channel was flushed by suctioning the detergent solution 
while the tip of the endoscope was placed in this agent. The en-
doscope was then moved to a separate room for disinfection 
where manual cleaning was first performed by brushing all 
accessible operating channels and scrubbing the whole outer 
surface of the endoscope with enzyme detergent moistened 
gauze again. After rinsing the endoscopes with water, it was 
then randomly placed in either COOLENDO or OER-A for 
disinfection.
Table 1. Comparison of COOLENDO and OER-A
COOLENDO OER-A
Manufacturer APEX Korea, Seoul, Korea Olympus Optical, Tokyo, Japan
LCG agent/trade name PHMB hydrochloride, alkyl DBAC/ECO-BIO SAN-Q OPA/CIDEX-OPA
Total cycle time, min 
Washing, min
Disinfection with USC, min
Rinsing, min
7
1
3
1
17
2
5
4
Scopes/cycle 1 scope/cycle 1 scope/cycle
List price (6/2011) $ 8,141 (KRW 8,800,000) $ 37,003 (KRW 40,000,000)
Ultrasonographic cleaning Yes Yes
PHMB, polyhexamethylenebiguanide; DBAC, dimethylbenzylammonium chloride; OPA, orthophthalaldehyde; LCG, liquid chemical germi-
cide; USC, ultrasonographic cleaning; KRW, Korean Won.SY Kim et al. 
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Endoscope reprocessing procedures of both of these AERs 
were similar: water washing, sterilization with disinfectant 
combined with ultrasonographic cleaning, and rinsing. Total 
time required to carry out endoscope reprocessing was 7 
minutes for COOLENDO with each main procedural time as 
follows: washing (1 minute), sterilization and ultrasonogra-
phic cleaning (3 minutes), and rinsing (1 minute). With OER-
A, it took 17 minutes with each procedural time as follows: wa-
shing (2 minutes), sterilization and ultrasonographic cleaning 
(5 minutes), rinsing (4 minutes). For sterilization, COOLEN-
DO and OER-A uses ECO-BIO SAN-Q (Choongwae Human-
tech, Seoul, Korea) and Cydex OPA (Johnson and Johnson, To-
kyo, Japan) as disinfectants, respectively (Table 1). ECO-BIO 
SAN-Q is a disinfectant whose major components are PHMB 
and DBAC. Cydex OPA is a widely used disinfectant whose 
major component is OPA.
To see whether microorganisms were actually present and 
cultured from the endoscopes before the reprocessing proce-
dure, samples were collected right after the completion of first 
16 endoscopic examinations (Table 2). After confirming that 
microorganisms were truly present in the majority of the cases 
before cleaning and disinfection, samples were collected only 
Table 2. Microorganisms Recovered before and after Endoscope Reprocessing from the First 16 Endoscopes
Endoscope Reprocessor
Before reprocessing After reprocessing
Tip (CFU) Working channel (CFU) Tip (CFU)
Working 
channel
1 COOLENDO Streptococcus vestibularis (>100) Streptococcus vestibularis (>100) None None
2 OER-A Streptococcus viridans group (60)
Staphylococcus capitis (8)
Streptococcus viridans group (>100) Pseudomonas 
putida (8)
None
3 OER-A Klebsiella pneumoniae (4)
Streptococcus salivarius (60)
Klebsiella pneumoniae (6)
Streptococcus salivarius (80)
Pseudomonas 
putida (8)
None
4 OER-A Kocuria varians (15)
Streptococcus salivarius (>100)
None None None
5 OER-A MRSA (6)
Streptococcus viridans group (>100)
MRSA (8 CFU/0.1 mL)
Streptococcus viridans group (80)
None None
6 COOLENDO Klebsiella pneumoniae (4)
Streptococcus viridans group (>100)
Staphylococcus epidermidis (20)
Klebsiella pneumoniae (4)
Streptococcus viridans group (>100)
None None
7 COOLENDO Bacillus species (80)
Klebsiella pneumoniae (4)
Streptococcus salivarius (50)
Klebsiella pneumoniae (16)
Streptococcus viridans group (>100)
None None
8 OER-A Corynebacterium species (>100)
Enterobacter aerogenes (8)
Enterobacter cloacae (20)
Streptococcus viridans group (>100)
Corynebacterium species (80)
Enterobacter aerogenes (20)
Streptococcus viridans group (>100)
None None
9 COOLENDO Streptococcus salivarius (20) Streptococcus salivarius (25 CFU/0.1 mL) None None
10 COOLENDO Enterococcus faecalis (group D) (>100) Enterococcus faecalis (group D) (4)
Streptococcus viridans group (10)
None None
11 OER-A Pseudomonas putida (>100)
Streptococcus salivarius (10)
Streptococcus viridans group (20)
Pseudomonas putida (2)
Streptococcus salivarius (8)
Streptococcus viridans group (20)
None None
12 COOLENDO Streptococcus viridans group (>100) Streptococcus viridans group (60) None None
13 OER-A Enterobacter cloacae (20)
Streptococcus viridans group (30)
Enterobacter cloacae (3)
Corynebacterium species (30)
None None
14 COOLENDO Pseudomonas aeruginosa (80)
Sphingomonas paucimobilis (30)
Streptococcus viridans group (>100)
Pseudomonas aeruginosa (30)
Streptococcus salivarius (6)
Streptococcus viridans group (20)
None None
15 COOLENDO Streptococcus viridans group (10) Streptococcus viridans group (>100) None None
16 OER-A Pseudomonas putida (>100) None None None
CFU, colony forming unit; MRSA, methicillin resistant Staphylococcus aureus. 112  Clin Endosc 2011;44:109-115
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after the termination of endoscope reprocessing. Two samples 
were collected from each endoscope, one from the endoscope 
tip and the other from working channel. The first sample was 
taken from the tip of the insertion tube using 0.9% NaCl so-
aked cotton swab, which was streaked onto blood agar plate. 
The second sample was obtained by flushing down 30 mL of 
0.9% NaCl through the working channel to be collected in a 
sterile tube, and the effluent was later filtered through a 0.22 
µm nitrocellulose membrane filter (Millipore, Billerica, MA, 
USA) which was plated onto blood agar plate.
14-17 The blood 
agar plate was incubated in CO2 incubator at 42°C for 48 
hours for isolation of Campylobacter spp., and at 35.5°C for 
48 hours for isolation of all the other bacteria. The number of 
colonies on each plate was counted and all cultured bacteria 
were identified (VITEK 2; BioMérieux, Marcy L’Ètoile, France). 
This study was approved by Institutional Review Board of Ko-
rea University Anam Hospital.
Statistical analysis
Endoscope reprocessing was first performed with 40 endo-
scopes as a pilot study in order to calculate the sample size. Bas-
ed on the result of the pilot study, sample size for non-inferiori-
ty analysis was calculated using PASS 2008 (NCSS LLC, Ka-
ysville, UT, USA). With 90% power at a significance level of 
5%, the minimal sample size required to detect a significant 
difference was calculated to be 86 endoscope reprocessings 
(43 endoscopes for each group), the data of which were used 
for final analysis. Statistical analysis was performed using the 
SPSS version 13.0 (SPSS Inc., Chicago, IL, USA). p-value of 
less than 0.05 was considered statistically significant.
RESULTS
Pilot study
A total of 40 endoscopes were reprocessed in a pilot study 
to calculate the sample size needed to carry out non-inferiori-
ty test comparing COOLENDO/PHMB-DBAC (n=20) and 
OER-A/OPA (n=20) (Table 3). The results of isolated micro-
organisms cultured from the samples collected before and 
after reprocessing the first 16 endoscopes are shown in Table 2. 
Before reprocessing, microorganisms were isolated from all 
samples taken from the tip and in the majority of samples col-
lected from the working channel. After reprocessing, Pseudo-
monas putida was isolated from the tip of two endoscopes re-
processed with OER-A/OPA and no organism was recovered 
from those reprocessed with COOLENDO/PHMB-DBAC. 
After completing the reprocessing procedure with 16 endo-
scopes, additional 24 endoscopes were reprocessed and this 
time, samples were collected only after finishing reprocessing 
procedure. No additional microorganisms were cultured from 
the samples, and the results of isolated microorganisms and 
colony count from 40 endoscopes after the reprocessing pro-
cedure are summarized in Table 3. In the end, no microorgan-
isms were cultured from the samples obtained from endo-
scopes reprocessed with COOLENDO/PHMB-DBAC but P. 
putida was isolated from two endoscopes reprocessed with 
OER-A/OPA.
Main study
The sample size calculation indicated that a total of 86 en-
doscope reprocessings were needed to perform non-inferior-
ity test (Table 3). Since 40 endoscopes had already been re-
processed during the pilot study, additional 46 endoscopes 
were randomly assigned again to be reprocessed with either 
COOLENDO/PHMB-DBAC (n=23) or OER-A/OPA (n=23). 
No microorganisms were subsequently isolated from endo-
scopes reprocessed with OER-A/OPA after P. putida was re-
covered from the two endoscopes in the pilot study. However, 
as for the endoscopes reprocessed with COOLENDO/PHMB-
DBAC, Staphylococcus hominis (5 colony forming unit [CFU]) 
was isolated from the working channel of an endoscope. Th-
erefore, the culture-positive rate was 2.33% (1/43) for COOL-
ENDO/PHMB-DBAC and 4.65% (2/43) for OER-A/OPA (Ta-
ble 3) and thus, the reprocessing efficacy of COOLENDO/
PHMB-DBAC was non-inferior to that of OER-A/OPA (p= 
0.032; confidence interval, -0.042 to 0.042).
Adverse events
No adverse events attributable to PHMB could be observed 
among healthcare workers in our endoscopy unit during the 
Table 3. The Culture Result and Microorganisms Recovered from 86 Endoscopes Reprocessed with Either COOLENDO or OER-A
Reprocessor Culture positive rate, % Culture site Cultured organisms (no. of colonies)
Pilot study (n=40) COOLENDO (n=20) 00.0 (0/20)
OER-A (n=20) 10.0 (2/20) Tip of insertion tube Pseudomonas putida (8 CFU)
Main study (n=46) COOLENDO (n=23) 4.35 (1/23) Working channel Staphylococcus hominis (5 CFU)
OER-A (n=23) 00.0 (0/23)
Total (n=86) COOLENDO (n=43) 2.33 (1/43)
OER-A (n=43) 4.65 (2/43)
CFU, colony forming unit.SY Kim et al. 
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study period. Among previously reported adverse events of 
OPA such as temporary skin discoloration, staining of cloth-
ing and surrounding surfaces due to direct contact with this ag-
ent,
18 only temporary skin discoloration was observed among 
endoscopists who did not wear gloves during the procedure. 
In our endoscopy unit, all the endoscopes are reprocessed by 
AERs always wearing appropriate gloves, fluid-resistant gowns 
and goggles in the adequately ventilated disinfection room. 
Most likely as a result of these preventive measures, many of the 
previously reported adverse events that occur by exposure to 
OPA vapors such as mucosal irritation, respiratory symptoms, 
IgE-mediated hypersensitivity reactions, eye irritation, and an-
aphylactic reactions
19,20 were not observed during the study 
period. Furthermore, no immediate adverse events relevant to 
the disinfectants used in our study (PHMB-DBAC and OPA) 
were observed among the patients following endoscopic ex-
aminations.
DISCUSSION
Our results show that reprocessing efficacy of COOLEN-
DO/PHMB-DBAC was not inferior to that of OER-A/OPA. 
On the whole, microorganisms were was isolated from one of 
the endoscopes reprocessed with COOLENDO/PHMB-DBAC 
(2.33%) and from two endoscopes reprocessed with OER-A/
OPA (4.65%).
COOLENDO uses ECO-BIO SAN-Q as disinfectant which 
is a mixture of PHMB and DBAC. PHMB is the major com-
ponent of ECO-BIO SAN-Q used in COOLENDO that has 
broad spectrum antimicrobial activity against microbes includ-
ing Gram-positive and Gram-negative bacteria, plaque-form-
ing and biofilm-building bacteria, some spore-forming bac-
teria, intracellular bacteria such as chlamydiae and mycoplasma, 
and fungi including Candida spp. as well as Aspergillus spp.
21-23 
PHMB also has been shown to inactivate HIV-1 and HSV in 
vitro.
24,25 PHMB is a widely used agent that has been mainly 
used for eye and wound antisepsis. In spite of extensive use 
of PHMB as preservative in cosmetics and personal care pro-
ducts, the frequency of sensitization remains low and only 3 
cases of anaphylactic reactions have been reported in the lit-
erature so far.
26-28 PHMB is classified as ‘practically nontoxic’ 
and no uptake of PHMB from intact skin has been demon-
strated.
12 Until now, PHMB has not been applied for endo-
scope reprocessing and COOLENDO is the first AER that uti-
lizes this agent as a disinfectant. In the current study, no adver-
se effects were observed either to the medical staffs reprocess-
ing the endoscopes, endoscopists or the patients, and the re-
sults of our study show that this agent is an effective disinfec-
tant. DBAC is a cationic surface-acting agent belonging to the 
quaternary ammonium group that has intermediate to low 
disinfection activity. In ECO-BIO SAN-Q, DBAC is combin-
ed to PHMB in order to broaden the spectrum of microbioci-
dal activity and to increase wetting properties.
29 Antimicro-
bial activity is amplified when the n-alkyl chain of quaternary 
ammonium compound length is increased by the combina-
tion of PHMB and DBAC.
29 
The reprocessing efficacy of both AERs used in our study 
is much better than that of the previous studies in which, the 
culture positive rate after reprocessing ranged from 10.7% to 
37.2%.
14,16,30 One of the reasons for this difference could be due 
to the fact that the AERs used in our study were equipped with 
ultrasonographic cleaning system compared with the previous 
AERs. Ultrasonographic cleaning uses high frequency sound 
waves to agitate the aqueous solution or organic compound 
and can remove material from hard-to-clean areas.
31 
Application of ultrasonographic cleaning not only improv-
ed reprocessing efficacy but also shortened the time required 
for reprocessing. This was more pronounced with COOLEN-
DO/PHMB-DBAC which only took 7 minutes to complete re-
processing, whereas OER-A/OPA needed 17 minutes to finish 
the procedure. Increasing the time efficiency for reprocessing 
could enhance the compliance of high-turnover endoscopy 
units to conform to the recommended reprocessing guidelines. 
In the first part of the pilot study with 16 endoscopes, vari-
ous kinds of bacteria including P. aeruginosa and MRSA were 
detected from the pre-reprocessing cultures of tip and work-
ing channel. This shows that fatal infection through the endo-
scopic procedure could occur if the reprocessing is insuffi-
ciently and not properly done. After reprocessing with AERs, 
the microorganism isolated from endoscopes reprocessed with 
OER-A/OPA was P. putida and that isolated from the endo-
scopes reprocessed with COOLENDO/PHMB-DBAC was S. 
hominis. P. putida is found in most soil and water habitats wh-
ere there is oxygen. P. putida, which belongs to the fluores-
cent group of Pseudomonas spp. has been recognized as a rare 
pathogen of bacteremia. Most reported cases of bacteremia 
with P. putida have been infections in immunocompromised 
patients or outbreak infections due to transfusion of contam-
inated blood or fluid.
32 S. hominis is a coagulase-negative mem-
ber of the bacterial genus Staphylococcus. S. hominis has a 
very low virulence and it occurs very commonly as a harmless 
commensal on human and animal skin. However, like many 
other coagulase-negative staphylococci, S. hominis may oc-
casionally cause infection in immunocompromised patients,
33 
and thus the presence of these organisms after reprocessing 
should not be overlooked.
This study has several limitations. First, owing to the fact 
that PCR for viral DNA was not performed, the efficacy ag-
ainst the disinfected virus could not been determined. Since tr-
ansmission of hepatitis B and C virus has also been previously 114  Clin Endosc 2011;44:109-115
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reported,
5,6 testing for the efficacy of ECO-BIO SAN-Q again-
st the aforementioned viruses should also be considered. How-
ever, viruses are known to be more easily killed at a lower th-
reshold compared to the bactria (i.e., with intermediate to low-
level disinfection).
34,35 In addition, the aforementioned viral 
transmissions occurred after manual cleaning which might not 
have been adequately performed. Therefore, the use of stan-
dardized AERs incorporating ultrasonographic cleaning and 
adequate disinfectant can be expected to prevent viral trans-
missions. Second, our study did not perform culture for my-
cobacterium. Because the incidence of tuberculosis is still not 
negligible in Korea, evaluation for mycobacteria would be an 
essential and important step to confirm the efficacy of endo-
scope reprocessing. However, bactericidal efficacy evaluation 
by Korean Institute of Tuberculosis demonstrated that >99.9% 
of this bacterium was killed after contact with PHMB for 3 
minutes and thus, it can be speculated that the efficacy would 
also be comparable in the clinical setting. Third, the sample 
size was only large enough to perform non-inferiority test and 
larger sample size would be necessary to perform equival-
ence trial and superiority trial. However, speculating from the 
result of the present non-inferiority trial, it could be inferred 
and expected that COOLEND/PHMB-DBAC would at least 
be equivalent to OER-A/OPA, albeit not superior.
In this study, we could see that COOLENDO that used PH-
MB-DBAC as disinfectant is non-inferior to OER-A which uti-
lized OPA as disinfectant. The microorganisms cultured from 
both AERs were those with low virulence and its microbial 
burden was also low. COOLENDO is faster than OER-A in 
terminating the reprocessing, thus being more advantageous 
with regards to the time factor. In addition, PHMB-DBAC was 
also safe in terms of side-effects. Concerns about possible tr-
ansmission of microorganisms during endoscopic procedures 
has been questioned for decades. With the increase in the de-
mand to perform endoscopy for diagnostic and therapeutic 
purposes, proper endoscope reprocessing cannot be overem-
phasized, even more so with increase in the number of immu-
nocompromised patients with acquired immune deficiency 
syndrome, organ transplant or those undergoing chemother-
apy who need endoscopy. Many efforts are being put into en-
hancing the efficacy, safety, and cost-effectiveness, and COOL-
ENDO/PHMB-DBAC seems to be a good alternative meeting 
all these needs.
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